September 13 Webinar: VARENICLINE (CHANTIX) CLINICAL UPDATE: Important information for Quitlines and

During this webinar Pfizer Scientist, Micheal Dutro, PharmD will discuss relevant new published clinical information on varenicline. Specific topics to be discussed during this webinar include: 

• Important recent updates to the US Chantix Label and the supporting studies:
  • EAGLES Study: Landmark trial evaluating  safety and efficacy of smoking cessation medications in smokers with and without psychiatric disease
  • Gradual Quit Study:  evaluating  a new method to quit with varenicline
  • Safety Updates
• Using lower doses of varenicline: effect on efficacy and tolerability
• Varenicline in a Quitline setting